⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for de novo aml

Every month we try and update this database with for de novo aml cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 MutationNCT02632708
Newly Diagnosed...
Untreated AML
AML Arising Fro...
AML Arising Fro...
AML Arising Aft...
AG-120
AG-221
cytarabine
daunorubicin
idarubicin
mitoxantrone
etoposide
18 Years - Servier
CPX-351+GO in Subjects 55 Years Old, or Older, With AMLNCT03878927
Acute Myeloid L...
CPX-351
Gemtuzumab Ozog...
55 Years - Weill Medical College of Cornell University
Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 MutationNCT02632708
Newly Diagnosed...
Untreated AML
AML Arising Fro...
AML Arising Fro...
AML Arising Aft...
AG-120
AG-221
cytarabine
daunorubicin
idarubicin
mitoxantrone
etoposide
18 Years - Servier
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: